Free Shipping on Orders $50+
|
Toggle Nav
Boehringer Ingelheim CALVENZA-03 EIV/EHV Equine Rhinopneumonitis + Influenza Vaccine 20mL/10 Dose
$245.09
For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in reduction of respiratory diseases caused by equine herpesvirus type 1 (EHV-1) and type 4 (EHV-4), and by equine influenza virus types A2 North American and A2 Eurasian.
**Ships Monday thru Thursday Only**
See our Pharmaceutical Quality Program for more info.
This product is non-returnable.
Availability:
In stock
Only 986 left
MPN
139136
Boehringer Ingelheim CALVENZA-03 EIV/EHV Equine Rhinopneumonitis + Influenza Vaccine 20mL/10 Dose
For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in reduction of respiratory diseases caused by equine herpesvirus type 1 (EHV-1) and type 4 (EHV-4), and by equine influenza virus types A2 North American and A2 Eurasian.
- Incorporates Florida sublineage Clade 1 (OH/03), Kentucky (KY/2/95), and Eurasian (NM/2/93) equine influenza strains
- Unique EHV-1 equine respiratory origin isolate
- Stimulates antibody to EHV-1 & EVH-4
- Carbimmune adjuvant
- Includes innovative pliable nasal applicator
- Flexible dose administration using intramuscular or intranasal techniques
- Minimal vaccine site reactions
Using aseptic technique inoculate horses IM with a 2 mL dose. Administer a second 2 mL dose IM in 3-4 weeks using a different injection site. Administer a third 2 mL dose in 3-4 weeks IM or IN.
| Item Number | BOE038 |
|---|---|
| MPN | 139136 |
| UPC | 012315132628 |
| Weight | 5.000000 |
| Brand | Boehringer Ingelheim |
| Item Returns | This item can be returned |
Write Your Own Review
Validate your login